The Federal Food, Drug and Cosmetic Act prohibits, among other matters, the introduction or delivery for introduction into interstate or foreign commerce or commerce within the District of Columbia or the territories, or the manufacture within the District of Columbia or one of the territories, of a drug that is misbranded. Section 502 (j) provides that a drug shall be deemed to be misbranded if it is dangerous to health when used in the dosage or with the frequency or duration prescribed, recommended or suggested in its labeling. The Food and Drug Administration has informally declared that there are a number of drugs which are in fact dangerous if consumed other than on expert advice and under constant supervision. There are other drugs, however, which may safely be distributed to the public for consumption in small doses under labels bearing adequate directions for use and adequate warnings against
Current Comment. JAMA. 1941;116(9):840. doi:10.1001/jama.1941.02820090040013
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: